The global wound & tissue care market was valued at USD 29,336.4 mn in 2018 and is expected to reach USD 44,991.9 mn by 2025 at a CAGR of 6.3% during the forecast period.
The global wound & tissue care market is witnessing growth due to increasing prevalence of diabetes, rapid growth in geriatric population, developments and innovations in wound care products, increasing funding for wound care research, and awareness programs for wound care treatment and management.
| Wound & Tissue Care Market Segmentation | |
| By Type | 1. Traditional adhesive bandages |
| 2. Negative pressure wound therapy | |
| 3. Antimicrobial dressings | |
| 4. Traditional gauze bandages | |
| 5. Foam dressings | |
| 6. Non-adherent bandages | |
| 7. Hydrocolloids | |
| 8. Film dressings | |
| 9. Growth factors | |
| 10. Bioengineered skin | |
| 11. Others | |
| By Application | 1. Surgical |
| 2. Trauma/Lacerations | |
| 3. Burns | |
| 4. Pressure ulcer | |
| 5. Venous ulcer | |
| 6. Diabetic ulcer | |
| By Region | 1. North America |
| 2. Europe | |
| 3. China | |
| 4. Japan | |
Chronic conditions such as diabetic foot ulcers that are not healed and venous leg ulcers are a tremendous burden on the health care system. While a little over half of diabetic foot ulcers will cure within 12 weeks, a year after occurrence, 13 percent will stay unhealed. Medicare recipients with diabetic foot ulcers are seen approximately 12 times a year by their outpatient health care providers and they are hospitalized approximately twice a year. Approximately 1 million Americans face diabetic foot ulcers every year, equivalent to more than USD 15 billion in annual healthcare spending. Additionally, more than three million Americans experience venous leg ulcer each year, adding an additional USD 2 billion or more to the nation's healthcare expenditure.
The Traditional adhesive bandages segment is expected to dominate the market throughout the forecast period
Based on the type, the market has been segmented into traditional adhesive bandages, negative pressure wound therapy, antimicrobial dressings, traditional gauze bandages, foam dressings, non-adherent bandages, hydrocolloids, film dressings, growth factors, bioengineered skin, and others. Among these, traditional adhesive bandages are dominating the market in the year 2018 and are expected to witness the same growth trend during the forecast period. In 2018, the traditional adhesive bandages segment accounted for 26.5% of the overall wound & tissue care market share and it is expected to grow at a CAGR of 5.9% over the forecast period.
Sticking plasters or dressings used for tiny wounds are adhesive bandages. These bandages are used for wounds that are not severe enough to require a full-size bandage. They defend wounds against additional injuries, friction, bacteria, and dirt. They cure injuries and carry skin cuts. As medicated or non-medicated bandages, adhesive bandages are accessible.
Based on applications, the surgical segment is expected to dominate the market during the forecast period
Based on applications, the market has been segmented as surgical, trauma/lacerations, burns, pressure ulcer, venous ulcer, and diabetic ulcer. Among these, the surgical segment accounts for the largest share in the global wound & tissue care market by application.
Surgical care is essential for managing diverse health conditions such as injuries, obstructed labour, malignancy, infections, and cardiovascular diseases and it is an indispensable component of a functioning health system. An increasing number of surgeries worldwide are expected to drive the wound & tissue care market for surgical applications. In 2018, surgical applications accounted for more than 60% of overall market share and are expected to grow at a CAGR of 6.5% over the forecast period.
North America to dominate the wound & tissue market throughout the forecast period
The North America wound & tissue care market size is expected to grow at a CAGR of 6.2% over the forecast period. Leading wound care companies operating in North America are Ethicon, Acelity, Medtronic, Cardinal Health, Medline, Baxter, 3M, Integra LifeSciences, MiMedx, and Mölnlycke. The increasing prevalence of diabetes, ulcers, and other chronic diseases is expected to propel the wound care market in this region. Additionally, the growing aging population will further create demand for wound & tissue care services in the coming years.
Company Profiles and Competitive Intelligence
The major players operating in the global wound & tissue care market are 3M, ABL Medical, Acelity, ACell, AquaMed, Amniox Medical, Inc, Angelini, Argentum Medical, LLC, ArjoHuntleigh, Arobella Medical, LLC, Baxter International Inc., Aesculap, Inc. - B. Braun, Cardinal Health, Coloplast A/S, ConvaTec, Inc, and other notable players.
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports
Table of Content
Chapter 1 Executive Summary
1.1 Global Wound & Tissue Care market overview
1.2 Wound & Tissue Care Segment by Type
1.2.1 Traditional adhesive bandages
1.2.2 Negative pressure wound therapy
1.2.3 Antimicrobial dressings
1.2.4 Traditional gauze bandages
1.2.5 Foam dressings
1.2.6 Non-adherent bandages
1.2.7 Hydrocolloids
1.2.8 Film dressings
1.2.9 Growth factors
1.2.10 Bioengineered skin
1.3 Wound & Tissue Care Segment by Application
1.3.1 Surgical
1.3.2 Trauma/Lacerations
1.3.3 Burns
1.3.4 Pressure ulcer
1.3.5 Venous ulcer
1.3.6 Diabetic ulcer
1.4 Global Wound & Tissue Care Market by Region
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.5 Global Wound & Tissue Care Market Size
1.5.1 Global Wound & Tissue Care Revenue (2014-2025)
Chapter 2 Global Wound & Tissue Care Market Competition by Manufacturers
2.1 Global Wound & Tissue Care Revenue Share by Manufacturers, 2018
2.2 Manufacturers Wound & Tissue Care Sites, Area Served, Product Types
2.3 Wound & Tissue Care Market Competitive Situation and Trends
2.3.1 Wound & Tissue Care Market Concentration Rate
2.3.2 Wound & Tissue Care Market Share of Top 3 and Top 5 Manufacturers
2.3.3 Mergers & Acquisitions, Expansion, New product development
Chapter 3 Company Profiles - Wound & Tissue Care Business
3.1 3M
3.1.1 Company overview
3.1.2 Product offerings
3.1.3 Financial performance
3.1.4 Recent developments
3.2 ABL Medical
3.2.1 Company overview
3.2.2 Product offerings
3.3 Acelity
3.3.1 Company overview
3.3.2 Product offerings
3.3.3 Financial performance
3.3.4 Recent developments
3.4 ACell
3.4.1 Company overview
3.4.2 Product offerings
3.4.3 Financial performance
3.5 AquaMed - Alliqua BioMedical
3.5.1 Company overview
3.5.2 Product offerings
3.5.3 Financial performance
3.6 Amniox Medical, Inc.
3.6.1 Company overview
3.6.2 Product offerings
3.6.3 Financial performance
3.7 Angelini
3.7.1 Company overview
3.7.2 Product offerings
3.7.3 Financial performance
3.8 Argentum Medical, LLC
3.8.1 Company overview
3.8.2 Product offerings
3.8.3 Financial performance
3.9 ArjoHuntleigh
3.9.1 Company overview
3.9.2 Product offerings
3.9.3 Financial performance
3.10 Arobella Medical, LLC
3.10.1 Company overview
3.10.2 Product offerings
3.10.3 Financial performance
3.11 Baxter International Inc.
3.11.1 Company overview
3.11.2 Product offerings
3.11.3 Financial performance
3.11.4 Recent developments
3.12 Aesculap, Inc. - B. Braun
3.12.1 Company overview
3.12.2 Product offerings
3.12.3 Financial performance
3.13 Cardinal Health
3.13.1 Company overview
3.13.2 Product offerings
3.13.3 Financial performance
3.14 Coloplast A/S
3.14.1 Company overview
3.14.2 Product offerings
3.14.3 Financial performance
3.14.4 Recent developments
3.15 ConvaTec, Inc
3.15.1 Company overview
3.15.2 Product offerings
3.15.3 Financial performance
3.15.4 Recent developments
3.16 Crawford Healthcare Ltd
3.16.1 Company overview
3.16.2 Product offerings
3.16.3 Financial performance
3.17 CryoLife, Inc.
3.17.1 Company overview
3.17.2 Product offerings
3.17.3 Financial performance
3.18 Smith & Nephew PLC
3.18.1 Company overview
3.18.2 Product offerings
3.18.3 Financial performance
3.19 Johnson & Johnson - ETHICON, INC.
3.19.1 Company overview
3.19.2 Product offerings
3.19.3 Financial performance
3.20 Integra Lifesciences
3.20.1 Company overview
3.20.2 Product offerings
3.20.3 Financial performance
3.21 MiMedx Group
3.21.1 Company overview
3.21.2 Product offerings
3.21.3 Financial performance
Chapter 4 Wound & Tissue Care Manufacturing Cost Analysis
4.1 Wound & Tissue Care Key Raw Materials Analysis
4.1.1 Key Raw Materials
4.1.2 Price Trend of Key Raw Materials
4.1.3 Key Suppliers of Raw Materials
4.2 Proportion of Manufacturing Cost Structure
4.3 Wound & Tissue Care Industrial Chain Analysis
Chapter 5 Marketing, Distributors, and Customer
5.1 Marketing Channel
5.1.1 Direct Channels
5.1.2 Indirect Channels
5.2 Wound & Tissue Care Distributors List
5.3 Wound & Tissue Care Customers
Chapter 6 Market Dynamics
6.1 Market Trends
6.2 Opportunities
6.3 Market Drivers
6.4 Challenges
6.5 Influence Factors
Chapter 7 Global Wound & Tissue Care Market Forecast
7.1 Global Wound & Tissue Care Revenue Forecast, 2019 – 2025 (USD Million)
7.1.1 Global Wound & Tissue Care Revenue and Growth Rate Forecast (2019-2025)
7.2 Global Wound & Tissue Care Revenue Forecast by Regions (2019-2025)
7.2.1 North America Revenue Forecast (2019-2025)
7.2.2 Europe Revenue Forecast (2019-2025)
7.2.3 China Revenue Forecast (2019-2025)
7.2.4 Japan Revenue Forecast (2019-2025)
7.3 Global Wound & Tissue Care Revenue Forecast by Type (2019-2025)
7.3.1 Traditional adhesive bandages Revenue Forecast (2019-2025)
7.3.2 Negative pressure wound therapy Revenue Forecast (2019-2025)
7.3.3 Antimicrobial dressings Revenue Forecast (2019-2025)
7.3.4 Traditional gauze bandages Revenue Forecast (2019-2025)
7.3.5 Foam dressings Revenue Forecast (2019-2025)
7.3.6 Non-adherent bandages Revenue Forecast (2019-2025)
7.3.7 Hydrocolloids Revenue Forecast (2019-2025)
7.3.8 Film dressings Revenue Forecast (2019-2025)
7.3.9 Growth factors Revenue Forecast (2019-2025)
7.3.10 Bioengineered skin Revenue Forecast (2019-2025)
7.4 Global Wound & Tissue Care Revenue Forecast by Application (2019-2025)
7.4.1 Surgical Wound & Tissue Care Revenue Forecast (2019-2025)
7.4.2 Trauma/Lacerations Wound & Tissue Care Revenue Forecast (2019-2025)
7.4.3 Burns Wound & Tissue Care Revenue Forecast (2019-2025)
7.4.4 Pressure ulcer Wound & Tissue Care Revenue Forecast (2019-2025)
7.4.5 Venous ulcer Wound & Tissue Care Revenue Forecast (2019-2025)
7.4.6 Diabetic ulcer Wound & Tissue Care Revenue Forecast (2019-2025)
Chapter 8 Research Findings and Conclusion
Chapter 9 Methodology and Data Source
9.1 Methodology/Research Approach
9.1.1 Phase I – Secondary Research
9.1.2 Phase II – Primary Research
9.1.3 Assumptions
9.1.4 Market Size Estimation
9.1.4.1 Top-Down Approach
9.1.4.2 Bottom-Up Approach
9.2 Data Source
9.2.1 Secondary Source
9.3 Disclaimer
Log in / Register
